3 - Gerd
3 - Gerd
Objectives
After completing this case, the student will be 5. Interpret pertinent laboratory parameters
able to: for nutritional implications and significance.
1. Apply knowledge of the pathophysiology 6. Analyze nutrition assessment data to evalu-
of gastroesophageal reflux disease (GERD) ate nutritional status and identify specific
in order to identify and explain common nutrition problems.
nutritional problems associated with this 7. Determine nutrition diagnoses and write
disease. appropriate PES statements.
2. Describe basic principles of drug action 8. Develop a nutrition care plan—with appro-
required for medical treatment of GERD. priate measurable goals, interventions, and
3. Understand the potential complications of strategies for monitoring and evaluation—
untreated GERD. that addresses the nutrition diagnoses of
4. Discuss the rationale for nutrition recom- this case.
mendations to minimize adverse symptoms
of GERD.
77
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
78 Unit Three Nutrition Therapy for Upper Gastrointestinal Disorders
Ranta Images/Shutterstock.com Patient Summary: 48-y.o. male here for evaluation and treatment for increased
and recurrent symptoms of indigestion.
History:
Onset of disease: Patient has been experiencing increased indigestion over
last year. Previously it was only at night but now he experiences indigestion
almost constantly. He has been taking Tums several times daily and has tried the herb fenugreek
and turmeric for relief of symptoms. Mr. Gupta has gained almost 30 lbs since he had knee
surgery 3 years ago, which he attributes to a decrease in his ability to run and not being able to find
a consistent replacement for this form of exercise. Patient states he plays with his children on the
weekends, but that is the extent of his physical activity. He states he probably has been eating and
drinking more over the last year, which he attributes to stress. He is worried about his family history
of heart disease, which is why he takes an aspirin each day. He has not changed his diet in any way
except for the addition of fenugreek and turmeric.
Medical history: Essential HTN—Dx 1 year ago
Surgical history: s/p R knee arthroplasty 5 years ago
Medications at home: Metoprolol 50 mg daily; 325 mg aspirin daily; multivitamin daily; 500 mg
ibuprofen twice daily for last month
Tobacco use: No
Alcohol use: Yes; 1–2 beers 1–2 times/week
Family history: What? CAD. Who? Father.
Demographics:
Marital status: Married—lives with wife and 2 sons
Spouse name: Saanvi
Number of children: 2 (ages 8 and 12)
Years education: BA
Language: English and Hindi
Occupation: Retail manager of local department store
Hours of work: M–F, works consistently in evenings and on weekends as well
Ethnicity: Indian
Religious affiliation: Hinduism
MD Progress Note:
General/Constitutional: Well-developed, overweight 48-year-old Indian male in mild distress.
HEENT: Head: normocephalic and atraumatic
Eyes: anicteric sclera, noninjected conjunctiva
Mouth: oral mucosa pink, dentition in good repair
Throat: pharynx pink without exudates
Neck: soft, supple, no palpable masses. No lymphadenopathy.
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Case 7 Gastroesophageal Reflux Disease 79
Cardiac: Regular rate and rhythm. Normal S1, S2. No murmurs, rubs, or gallops.
Pulmonary/Chest: Lungs are clear to auscultation bilaterally.
Abdominal: Abdomen soft, nontender, with normoactive bowel sounds in all four quadrants. Liver
percusses approx 8 cm at the midclavicular line, one fingerbreadth below the right costal margin.
Epigastric tenderness without rebound or guarding.
Extremities: Normal range of motion in all four extremities. No cyanosis or clubbing or peripheral
edema.
Neurological: Conscious, alert, and oriented. Cranial nerves II through XII are intact grossly and
symmetrically. No focal neurologic deficit.
Skin: Skin is warm and dry. No rashes or ulcerations noted.
Medical Tx plan: Hematology, Chem 24, Ambulatory 48-hour pH monitoring with Bravo™ pH moni-
toring system, Barium esophagram—request radiologist to attempt to demonstrate reflux using
abdominal pressure and positional changes; Endoscopy with biopsy to r/o H. pylori infection; Begin
omeprazole 30 mg every am; Decrease aspirin to 75 mg daily; D/C self-medication of ibuprofen
daily; Nutrition consult.
J. Li, MD
Nutrition:
History: Patient relates he has gained almost 30 lbs since his knee surgery. He attributes
this to a decrease in his ability to run, and he has not found a consistent replacement for this
form of exercise. He plays with his children on weekends, but that is the extent of his physical
activity. He states he probably has been eating and drinking more over the last year, which he
attributes to stress with his busy lifestyle and long work hours. He is worried about his family
history of heart disease, which is why he takes an aspirin each day. He has not really followed
any diet restrictions for health concerns. He eats a combination of traditional Indian foods
along with more American-style food choices. He has lived in the United States since his high
school years, so he does not follow any strict dietary practices related to his religious back-
ground of Hinduism.
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
80 Unit Three Nutrition Therapy for Upper Gastrointestinal Disorders
24-hr recall:
(At home PTA): 2 scrambled eggs, naan; hot black tea
At work: 3 12-oz Diet Pepsis
Lunch: Leftover curry with spinach, chickpeas, rice—2 c
Hot black tea
Late afternoon: 2 c chips, 1 beer
Dinner: Lentil dal—2 c. over approx. 2 c rice
2 slices naan
2 c hot chai tea
Bedtime: 2 c ice cream
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Case 7 Gastroesophageal Reflux Disease 81
Laboratory Results
Ref. Range 11/1 0700
Chemistry
Sodium (mEq/L) 136–145 144
Potassium (mEq/L) 3.5–5.1 4.5
Chloride (mEq/L) 98–107 102
Carbon dioxide (mEq/L) 23–29 25
BUN (mg/dL) 6–20 8
Creatinine serum (mg/dL) 0.6–1.1 F 0.9
0.9–1.3 M
Uric acid (mg/dL) 2.8–8.8 F 5.1
4.0–9.0 M
Est GFR, non-Afr Amer >60 117
(mL/min/1.73 m2)
Glucose (mg/dL) 70–99 91
Phosphate, inorganic (mg/dL) 2.2–4.6 3.8
Magnesium (mg/dL) 1.5–2.4 1.9
Calcium (mg/dL) 8.6–10.2 8.9
Bilirubin total (mg/dL) ≤1.2 0.9
Bilirubin, direct (mg/dL) <0.3 0.05
Protein, total (g/dL) 6–7.8 6.3
Albumin (g/dL) 3.5–5.5 4.5
Prealbumin (mg/dL) 18–35 31
Alkaline phosphatase (U/L) 30–120 83
ALT (U/L) 4–36 11
AST (U/L) 0–35 9
CPK (U/L) 30–135 F 71
55–170 M
Lactate dehydrogenase (U/L) 208–378 210
Cholesterol (mg/dL) <200 245 !
HDL-C (mg/dL) >50 F, >40 M 52
VLDL (mg/dL) 7–32 35 !
LDL (mg/dL) 0–99 157 !
(Continued)
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
82 Unit Three Nutrition Therapy for Upper Gastrointestinal Disorders
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Case 7 Gastroesophageal Reflux Disease 83
Note: Values and units of measurement listed in these tables are derived from
several resources. Substantial variation exists in the ranges quoted as “normal”
and these may vary depending on the assay used by different laboratories.
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
84 Unit Three Nutrition Therapy for Upper Gastrointestinal Disorders
Case Questions
I. Understanding the Disease and Pathophysiology
1. How and where is acid produced in the stomach and how is acid production controlled
within the gastrointestinal tract?
2. What role does lower esophageal sphincter (LES) pressure play in the etiology of
gastroesophageal reflux disease? What factors affect LES pressure?
5. Identify the patient’s signs and symptoms that could suggest the diagnosis of
gastroesophageal reflux disease.
7. What risk factors does the patient present with that might contribute to his diagnosis?
(Be sure to consider lifestyle, medical, and nutritional factors.)
8. The MD has decreased the patient’s dose of daily aspirin and recommended
discontinuing his ibuprofen. Why? How might aspirin and other NSAIDs affect
gastroesophageal disease?
9. The MD has prescribed omeprazole. What class of medication is this? What is the basic
mechanism of the drug? What other drugs are available in this class? What other groups of
medications are used to treat GERD?
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Case 7 Gastroesophageal Reflux Disease 85
12. Calculate energy and protein requirements for Mr. Gupta. How would this recommen-
dation be modified to support a gradual weight loss?
13. Mr. Gupta and his wife are originally from India. Are there components of their traditional
diet that may aggravate his symptoms of GERD?
14. What considerations related to Hinduism should you keep in mind when assessing
Mr. Gupta’s diet?
15. Estimate his caloric intake from his 24-hour recall. How does this compare to your
calculated energy requirements?
16. Are there any abnormal labs that should be addressed to improve Mr. Gupta’s overall
health? Explain.
17. Mr. Gupta’s history includes the use of fenugreek and turmeric as alternative treatments for
his symptoms of GERD. Examine the evidence regarding these supplements. What could
you tell Mr. Gupta? Are there any concerns with the ingestion of these supplements?
18. What other components of lifestyle modification would you address to help treat his
diagnosis?
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
86 Unit Three Nutrition Therapy for Upper Gastrointestinal Disorders
V. Nutrition Intervention
20. Determine the appropriate intervention for each nutrition diagnosis.
21. Does the long-term use of proton pump inhibitors have nutritional or other health
consequences? Are there specific interventions that you might implement to address
these effects?
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Case 7 Gastroesophageal Reflux Disease 87
Bibliography https://www.niddk.nih.gov/health-information
/digestive-diseases/acid-reflux-ger-gerd-adults
Academy of Nutrition and Dietetics Nutrition Care /eating-diet-nutrition. Accessed February 11, 2020.
Manual. https://www.nutritioncaremanual.org Nahikian-Nelms ML. Nutrition assessment: Foundation
/client_ed.cfm?ncm_client_ed_id=165. Accessed of the nutrition care process. In Nelms M, Sucher K.
January 22, 2020. Nutrition Therapy and Pathophysiology. 4th ed.
Corsonello A, Lattanzio F, Bustacchini S, et al. Adverse Belmont, CA: Cengage Learning; 2019:38–75.
events of proton pump inhibitors: Potential mecha- Nelms MN. Diseases of the upper gastrointestinal tract.
nisms. Curr Drug Metab. 2018;19:142–154. In Nelms M, Sucher K. Nutrition Therapy and Patho-
Esmaillzadeh A, Keshteli AH, Feizi A, Zaribaf F, Feinle- physiology. 4th ed. Belmont, CA: Cengage Learning;
Bisset C, Adibi P. Patterns of diet-related practices 2019:342–378.
and prevalence of gastro-esophageal reflux disease. Patrick L. Gastroesophageal reflux disease (GERD): A
Neurogastro Motil. 2013;25:831–e638. review of conventional and alternative treatments.
Freedberg DE, Kim LS, Yang YX. The risks and benefits Altern Med Rev. 2011;16(2):116–133.
of long-term use of proton-pump inhibitors: Expert Pronsky ZM, Crowe JP. Food and Medication Interaction,
review and best practice advice from the American 19th ed. Birchrunville, PA: Food-Medication Interac-
Gastroenterological Association. Gastroenterology. tions; 2018.
2017;152:796–715. Health care providers’ handbook on Hindu patients.
Katz PO, Gerson LB, Vila MF. Diagnosis and manage- Queensland Government. https://www.health.qld
ment of gastroesophageal disease. Am J Gastroenterol. .gov.au/multicultural/health_workers/hbook-hindu.
2013;108:308–328. Updated October 1, 2013. Accessed January 22, 2020.
Kittler P, Sucher K, Nelms M. Food and religion. In Kittler Richter JE, Rubenstein JH. Presentation and epidemiology
P, Sucher K, Nelms M. Food and Culture 6th ed. of gastroesophageal reflux disease. Gastroenterology.
Belmont, CA: Cengage Learning; 2011:94–97. 2018;154:267–276.
Kahrilas PJ, Hirano I. Diseases of the esophagus. In Sethi S, Richter JE. Diet and gastoesophageal reflux
Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo disease: Role in pathogenesis and management. Curr
DL, Loscalzo J., eds. Harrison’s Principals of Internal Opin Gastroenterol. 2017;33:107–111
Medicine. 20th ed. New York, NY: McGraw-Hill; Singh M, Lee J, Gupta N, et al. Weight loss can lead to
2018. http://accessmedicine.mhmedical.com/content resolution of gastroesophageal reflux disease of
.aspx?bookid=2129§ionid=192282054. Accessed symptoms: A prospective intervention trial. Obesity.
February 11, 2020. 2013;21:284–290.
Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden Sung Kim J, Byung-Wook K. Are diet and micronutri-
CW, Vakil N. ACG and CAG clinical guideline: ents effective in treating gastroesophageal reflux
Management of dyspepsia. Am J Gastroenterol. disease especially in women? J Neurogastroenterol.
2017;112:988–1038. 2019;25:1–2.
National Institute of Diabetes and Digestive and Kidney
Diseases. Eating, Diet, & Nutrition for GER & GERD.
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2022 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.